Growth Metrics

Microbot Medical (MBOT) Net Margin (2016)

Microbot Medical's Net Margin history spans 7 years, with the latest figure at 5775.44% for Q3 2016.

  • For the quarter ending Q3 2016, Net Margin rose 2147976.0% year-over-year to 5775.44%, compared with a TTM value of 24179.28% through Dec 2016, up 758910.0%, and an annual FY2015 reading of 31842.04%, changed N/A over the prior year.
  • Net Margin for Q3 2016 was 5775.44% at Microbot Medical, up from 30295.83% in the prior quarter.
  • The five-year high for Net Margin was 12.57% in Q4 2014, with the low at 43550.75% in Q1 2015.
  • Average Net Margin over 5 years is 11583.22%, with a median of 1926.61% recorded in 2012.
  • Year-over-year, Net Margin plummeted -4330909bps in 2015 and then surged 2147976bps in 2016.
  • Tracing MBOT's Net Margin over 5 years: stood at 2919.28% in 2012, then soared by 91bps to 255.56% in 2013, then skyrocketed by 95bps to 12.57% in 2014, then plummeted by -234860bps to 29536.33% in 2015, then soared by 80bps to 5775.44% in 2016.
  • Per Business Quant, the three most recent readings for MBOT's Net Margin are 5775.44% (Q3 2016), 30295.83% (Q2 2016), and 42469.06% (Q1 2016).